Clark Capital Management Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $214K | Sell |
481
-12
| -2% | -$5.34K | ﹤0.01% | 410 |
|
|
2025
Q1 | $239K | Sell |
493
-47
| -9% | -$22.8K | ﹤0.01% | 401 |
|
|
2024
Q4 | $217K | Sell |
540
-63
| -10% | -$25.4K | ﹤0.01% | 406 |
|
|
2024
Q3 | $280K | Buy |
603
+64
| +12% | +$29.8K | ﹤0.01% | 366 |
|
|
2024
Q2 | $253K | Buy |
+539
| New | +$253K | ﹤0.01% | 361 |
|
|
2021
Q2 | – | Sell |
-1,346
| Closed | -$289K | – | 370 |
|
|
2021
Q1 | $289K | Buy |
1,346
+485
| +56% | +$104K | ﹤0.01% | 318 |
|
|
2020
Q4 | $203K | Hold |
861
| – | – | ﹤0.01% | 338 |
|
|
2020
Q3 | $234K | Buy |
861
+10
| +1% | +$2.72K | ﹤0.01% | 298 |
|
|
2020
Q2 | $247K | Sell |
851
-573
| -40% | -$166K | ﹤0.01% | 285 |
|
|
2020
Q1 | $339K | Sell |
1,424
-413
| -22% | -$98.3K | 0.01% | 252 |
|
|
2019
Q4 | $402K | Sell |
1,837
-43
| -2% | -$9.41K | 0.01% | 269 |
|
|
2019
Q3 | $319K | Buy |
1,880
+41
| +2% | +$6.96K | 0.01% | 269 |
|
|
2019
Q2 | $337K | Buy |
1,839
+564
| +44% | +$103K | 0.01% | 258 |
|
|
2019
Q1 | $235K | Buy |
+1,275
| New | +$235K | 0.01% | 277 |
|